Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Evette Mitkov

Invo Fertility Stock Is Plunging After White House Announcement

Valuations Spur Mixed Analyst Sentiment

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House announcements aimed at making fertility treatments more affordable and accessible.

What Happened: According to Reuters, the Trump administration made a deal with drugmaker Merck KGaA (OTC:MKGAF) to dramatically cut the cost of IVF medications. Under the agreement, Merck's fertility drugs — like Gonal-f, Ovidrel, and Cetrotide — will be heavily discounted when used for IVF treatment, saving patients approximately $2,200 per treatment cycle.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.